A low allergen diet is a significant intervention in infantile colic: Results of a community-based study - 12/09/11
Abstract |
Background: The effect of diet change in 38 bottle-fed and 77 breast-fed “colicky” infants, referred from community-based pediatric facilities was studied over a 1-week period in a double-blind (within each feeding mode), randomized, placebo-controlled trial. Methods: Bottle-fed infants were assigned to either casein hydrolysate or cow's milk formula. All mothers of breast-fed infants were started on an artificial color-free, preservative-free, additive-free diet and also randomized to an active low allergen diet (milk-, egg-, wheat-, nut-free) or a control diet. Results: The response to diet was assessed on day 1 and day 8 with the use of a previously validated infant distress chart on which parents recorded distress levels. If successful outcome was defined as a reduction in distress of 25% or more, after adjusting for age and feeding mode, infants on active diet had a significantly higher rate of improvement than those on the control diet (odds ratio, 2.32; 95% confidence interval, 1.07-5.0; p = 0.03). Analysis of the day 8 to day 1 distress ratio, again adjusted for age and feeding mode, showed that infants on the active diet had distress reduced by 39% (95% confidence interval, 26-50) compared with 16% (95% confidence interval, 0-30) for those on the control diet (p = 0.012). Conclusion: The results suggest a period of dietary modification with a low allergen diet and appropriate nutritional support should be considered in healthy infants with colic. (J ALLERGY CLIN IMMUNOL 1995;96:886-92.)
Le texte complet de cet article est disponible en PDF.Keywords : Infantile colic, food protein intolerance, dietary change
Abbreviations : CI, LR, MANOVA, OR
Plan
From aRoyal Children’s Hospital, Melbourne; b Department of Statistics, University of Melbourne; and cMurdoch Institute for Research into Birth Defects, Melbourne. |
|
Supported by a grant from Mead Johnson Nutritionals, International Division of Bristol-Myers Squibb Company, USA. |
|
Reprint requests: David J. Hill, FRACP, Director, Department of Allergy, Royal Children's Hospital, Parkville 3052, Melbourne, Australia. |
|
1/1/64147 |
Vol 96 - N° 6
P. 886-892 - décembre 1995 Retour au numéroBienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?